Dominican Republic vs New Zealand: Deaths from cancer
Dominican Republic
11,350 deaths
in 2021
New Zealand
10,505 deaths
in 2021
Dominican Republic rank
84th
New Zealand rank
87th
Deaths from cancer over time
- Dominican Republic
- New Zealand
How they compare
Dominican Republic currently reports 11,350 deaths against 10,505 deaths in New Zealand, a difference of 845 deaths.
That makes Dominican Republic's figure about 1.1 times New Zealand's.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was New Zealand ahead.
Dominican Republic ranks 84th and New Zealand ranks 87th of 194 countries.
Across the 3 decades both report, Dominican Republic averaged higher in 2 and New Zealand in 1.
Head to head by decade
| Decade | Dominican Republic | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7,169 deaths | 7,962 deaths | 792.74 deaths | New Zealand |
| 2010s | 9,933 deaths | 9,302 deaths | 630.75 deaths | Dominican Republic |
| 2020s | 11,365 deaths | 10,162 deaths | 1,204 deaths | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from cancer, Dominican Republic or New Zealand?
- Dominican Republic, at 11,350 deaths against 10,505 deaths in New Zealand as of 2021.
- What is the difference in deaths from cancer between Dominican Republic and New Zealand?
- 845 deaths, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and New Zealand?
- 22 years are reported by both, from 2000 to 2021.
- How do Dominican Republic and New Zealand rank globally for deaths from cancer?
- Dominican Republic ranks 84th and New Zealand ranks 87th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes.